L-DOPA attenuates nicotine withdrawal-induced behaviors in rats

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 4, 2011, Pages 552-558

  Ohmura, Yu ^a,b   Jutkiewicz, Emily M ^a   Domino, Edward F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Levodopa; Quit smoking aids; Smoking; Stop smoking aids; Tobacco

Indexed keywords

BENSERAZIDE; LEVODOPA METHYL ESTER; NICOTINE; NICOTINE TARTRATE; TARTARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; DOPAMINE AGENTS; LEVODOPA; MALE; MOTOR ACTIVITY; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; NICOTIANA TABACUM; RATTUS;

EID: 79953110868     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.02.007     Document Type: Article

References (48)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 2000 American Psychiatric Association Washington DC
2. A. Arai, M. Tomiyama, K. Kannari, T. Kimura, C. Suzuki, and M. Watanabe Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter Synapse 62 8 2008 632 635 (Pubitemid 351951301)
3. N.L. Benowitz, F. Kuyt, and P. Jacob III Circadian blood nicotine concentrations during cigarette smoking Clin Pharmacol Ther 32 1982 758 764 (Pubitemid 13093847)
4. K. Cahill, and M. Ussher Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation Cochrane Database Syst Rev 4 2007 CD005353 [Oct 17]
5. M.A. Catania, F. Firenzuoli, A. Crupi, C. Mannucci, A.P. Caputi, and G. Calapai Hypericum perforatum attenuates nicotine withdrawal signs in mice Psychopharmacol 169 2003 186 189 (Pubitemid 37129970)
6. R. Chen, M. Zhang, S. Park, and M.E. Gnegy C57BL/6J mice show greater amphetamine-induced locomotor activation and dopamine efflux in the striatum than 129S2/SvHsd mice Pharmacol Biochem Behav 87 2007 158 163 (Pubitemid 46855830)
7. A.C. Collins, Y. Luo, S. Selvaag, and M.J. Marks Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion J Pharmacol Exp Ther 271 1994 125 133 (Pubitemid 24333121)
8. I.M. Colrain, J. Trinder, and G.E. Swan The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations Nicotine Tob Res 6 2004 913 925 (Pubitemid 40124751)
9. J.F. Cryan, D. Hoyer, and A. Markou Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents Biol Psychiat 34 2003 49 58 (Pubitemid 36776723)
10. J.M. Davis, Z. Zhao, H.S. Stock, K.A. Mehl, J. Buggy, and G.A. Hand Central nervous system effects of caffeine and adenosine on fatigue Am J Physiol Regul Integr Comp Physiol 284 2003 R399 R404
11. M.J. Detke, M. Rickels, and I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacol 121 1995 66 72
12. E.F. Domino, and H. Tsukada Nicotine sensitization of monkey striatal dopamine release Eur J Pharmacol 607 2009 91 95
13. A. Eltayb, M.L. Wadenberg, and T.H. Svensson Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa Biol Psychiat 58 2005 337 343 (Pubitemid 41133628)
14. M.M. Faraday, B.M. Elliott, and N.E. Grunberg Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration Pharmacol Biochem Behav 70 2001 475 489 (Pubitemid 34131642)
15. H. Gäddnäs, K. Pietilä, and L. Ahtee Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice Behav Brain Res 113 2000 65 72 (Pubitemid 30645544)
16. T.D. Geracioti, A.S. West, D.G. Baker, K.K. Hill, N.N. Ekhator, and M.D. Wortman Low CSF concentration of dopamine metabolite in tobacco smokers Am J Psychiat 156 1999 130 132 (Pubitemid 29034891)
17. K.R. Hamilton, S.S. Berger, M.E. Perry, and N.E. Grunberg Behavioral effects of nicotine withdrawal in adult male and female rats Pharmacol Biochem Behav 92 2009 51 59
18. K.R. Hamilton, E. Perry, S.S. Berger, and N.E. Grunberg Behavioral effects of nicotine withdrawal differ by genetic strain in male and female adolescent rats Nicotine Tob Res 12 12 2010 1236 1245
19. D.R. Helton, D.L. Modlin, J.P. Tizzano, and K. Rasmussen Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity Psychopharmacol 113 1993 205 210 (Pubitemid 24001993)
20. B.E. Hildebrand, G.G. Nomikos, P. Hertel, B. Schilström, and T.H. Svensson Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome Brain Res 779 1998 214 225 (Pubitemid 28039954)
21. J.R. Hughes Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review Nicotine Tob Res 9 3 2007 329 339 (Pubitemid 46404265)
22. J.R. Hughes Smoking and suicide: a brief overview Drug Alcohol Depend 98 2008 169 718
23. R.D. Hurt, E. Ahlskog, G.A. Croghan, K.P. Offord, T.D. Wolter, and I.T. Croghan Carbidopa/levodopa for smoking cessation: a pilot study with negative results Nicotine Tob Res 2 2000 71 78
24. E.M. Jutkiewicz, M.M. Torregrossa, K. Sobczyk-Kojiro, H.I. Mosberg, J.E. Folk, and K.C. Rice Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects Eur J Pharmacol 531 1-3 2006 151 159 (Pubitemid 43202228)
25. E.M. Jutkiewicz, M.G. Baladi, J.E. Folk, K.C. Rice, and J.H. Woods The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5- dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N, N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats J Pharmacol Exp Ther 324 2008 714 724 (Pubitemid 351185827)
26. K. Kannari, H. Shen, A. Arai, M. Tomiyama, and M. Baba Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters Neurosci Lett 402 1-2 2006 62 65 (Pubitemid 43766440)
27. J.E. Kelsey, O. Harris, and J. Cassin The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease Behav Brain Res 203 2009 304 307
28. H. Kompagne, G. Bárdos, G. Szénási, I. Gacsályi, L.G. Hársing, and G. Lévay Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats World Health Organization 2008
29. M.G. LeSage, D.E. Keyler, D. Shoeman, D. Raphael, G. Collins, and P.R. Pentel Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine Pharmacol Biochem Behav 72 2002 279 289 (Pubitemid 34251337)
30. D.H. Malin, and P. Goyarzu Rodent models of nicotine withdrawal syndrome Handb Exp Pharmacol 192 2009 401 434
31. D.H. Malin, J.R. Lake, P. Newlin-Maultsby, L.K. Roberts, J.G. Lanier, and V.A. Carter Rodent model of nicotine abstinence syndrome Pharmacol Biochem Behav 43 1992 779 784
32. D.H. Malin, J.R. Lake, T.D. Smith, H.N. Khambati, R.L. Meyers-Paal, and A.L. Montellano Bupropion attenuates nicotine abstinence syndrome in the rat Psychopharmacol 184 2006 494 503 (Pubitemid 43255866)
33. C. Mannucci, M. Tedesco, M. Bellomo, A.P. Caputi, and G. Calapai Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke Neurochem Int 49 2006 481 486 (Pubitemid 44209297)
34. M.J. Marks, J.R. Pauly, S.D. Gross, E.S. Deneris, I. Hermans-Borgmeyer, and S.F. Heinemann Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment J Neurosci 12 1992 2765 2784
35. R. Miyata, T. Sasaki, M. Hayashi, S. Araki, M. Shimohira, and J. Kohyama Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A Brain Dev 32 8 2010 685 687
36. Y. Nomura, and M. Segawa Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder: a hypothesis Brain Dev 25 Suppl. 1 2003 S37 S42
37. P.E. Paulson, D.M. Camp, and T.E. Robinson Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats Psychopharmacol 103 1991 480 492
38. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 5604 1977 730 732 (Pubitemid 8073804)
39. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur J Pharmacol 47 1978 379 391
40. M. Quik, T. Bordia, M. Okihara, H. Fan, M.J. Marks, and J.M. McIntosh L-DOPA treatment modulates nicotinic receptors in monkey striatum Mol Pharmacol 64 2003 619 628 (Pubitemid 37048565)
41. P. Rada, K. Jensen, and B.G. Hoebel Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens Psychopharmacol 157 2001 105 110 (Pubitemid 32758966)
42. S. Rahman, J. Zhang, E.A. Engleman, and W.A. Corrigall Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study Neurosci 129 2004 415 424 (Pubitemid 39388860)
43. D. Rylkova, J. Boissoneault, S. Isaac, M. Prado, H.P. Shah, and A.W. Bruijnzeel Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats Neuropeptides 42 2008 215 227
44. A.J. Schlosberg, and J.A. Harvey Effects of L-dopa and L-5-hydroxytryptophan on locomotor activity of the rat after selective or combined destruction of central catecholamine and serotonin neurons J Pharmacol Exp Ther 211 1979 296 304 (Pubitemid 10214540)
45. H. Takahashi, Y. Takada, N. Nagai, T. Urano, and A. Takada Effects of nicotine and footshock stress on dopamine release in the striatum and nucleus accumbens Brain Res Bull 45 1998 157 162 (Pubitemid 28027797)
46. S. Takayasu, T. Sakurai, S. Iwasaki, H. Teranishi, A. Yamanaka, and S.C. Williams A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice Proc Natl Acad Sci U S A 103 2006 7438 7443 (Pubitemid 43727851)
47. S.R. Wachtel, and E.D. Abercrombie L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors J Neurochem 63 1994 108 117
48. World Heatlh Organization The ICD-10 classification of mental and behavioural disorders Diagnostic criteria for research. Geneva, Switzerland: World Health Organization 1993